News244d
Which of the breakthrough weight-loss medicines can you get in SA?
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...
The Irish Times view on obesity medication: weighing up the balance
Obesity has a major impact on health and its economic cost could be up €1. 5 billion a year, according to HSE figures ...
UPI3d
GLP-1 medications show promise in slowing kidney disease progression
Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes ... and lower health care costs," she added in a university news release.
healthday on MSN3d
GLP-1 Meds Can Work Wonders for Kidney Health
Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo ...
Health and Me on MSN2d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney Disease
A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...
How you could soon be offered weight loss jabs at work - as new insurance scheme is announced
Until now, the drugs have only been available from specialist NHS clinics or private pharmacies, costing around £150 to £200 ...
Medscape1d
Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
pharmaphorum2d
The race for obesity drug assets heats up
This can be explained by the first generation weight loss product that Novo Nordisk had launched, Saxenda (liraglutide ... which has been estimated to cost the US between $147 billion and ...